Immunogenicity of a universal HIV-1 vaccine vectored by DNA, MVA and ChAdV-63 in a phase I/IIa clinical trial

Immunogenicity of a universal HIV-1 vaccine vectored by DNA, MVA and ChAdV-63 in a phase I/IIa clinical trial

Show other versions (2)
Bibliographic Details
Main Authors: Hanke, T, Borthwick, N, Ahmed, T, Hayton, E, Ebrahimsa, U, Rose, A, Black, A, Yang, H, Hancock, G, Colloca, S, Nicosia, A, Mcmichael, A, Dorrell, L
Format: Conference item
Published: 2012

Similar Items